Saturday 17 October 2026 Export ARQT’s income statement to Excel — free account

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024. In the quarter to June 2026, revenue grew 59.3%, EPS grew 184.6%, free cash flow grew 228.0% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

28.82 0.28 −0.96%

Follow ARQT

Alert me

Market cap: $3.7B
P/E: 131×
Fwd P/E: 196×
Dividend yield: —
F-score: 4/9
Altman Z: 6.98
Beneish M: −1.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	7	6	4	6	+8 more TTM periods Free account
ROE Full definition →	15.86%	(1.43%)	(9.30%)	(28.17%)
ROA Full definition →	6.78%	(0.59%)	(4.13%)	(10.97%)
ROIC Full definition →	23.62%	2.69%	(9.91%)	(31.79%)
Return on Tangible Assets Full definition →	9.25%	(0.86%)	(5.71%)	(17.68%)
Average Days of Receivables Full definition →	122.06	126.79	141.92	132.16
Free Cash Flow per Share Full definition →	0.30	0.21	(0.17)	(0.38)
Free Cash Flow Full definition →	39.07	26.99	(21.31)	(48.24)
Capital Expenditures Full definition →	(0.24)	—	(15.69)	(15.69)
Other line items
Cash ROIC Full definition →	6.87%	5.16%	(4.10%)	(10.53%)
Accounts Receivable Turnover Full definition →	3.54	3.62	3.43	3.63
Accounts Payable Turnover Full definition →	3.79	1.76	2.74	2.54
Inventory Turnover Full definition →	1.49	1.39	1.98	1.75
Average Days of Payables Full definition →	58.65	177.38	124.61	66.28
Days of Inventory on Hand Full definition →	345.31	362.50	225.14	256.42
Tax Rate Full definition →	(0.03)	0.71	0.08	0.02
Research and Development Expense of Revenue Full definition →	19.62%	21.69%	20.49%	22.36%
Selling, General and Administrative Expense of Revenue Full definition →	64.14%	68.48%	73.01%	79.64%
Share Based Compensation of Revenue Full definition →	9.39%	9.93%	10.73%	12.49%
Interest Coverage Full definition →	2.47	0.24	(1.01)	(2.61)
Operating CF/Net income Full definition →	1.38	(11.36)	0.35	0.73
Depreciation/Fixed assets Full definition →	1.50	0.80	2.47	1.00
Capex/Depreciation Full definition →	(0.18)	0.00	(6.10)	(12.90)
Revenue per Share Full definition →	3.55	3.21	2.96	2.49
Operating CF per Share Full definition →	0.30	0.21	(0.04)	(0.26)
Capex per Share Full definition →	0.00	0.00	(0.12)	(0.12)
Capex to Sales Full definition →	0.00	0.00	0.04	0.05

Show all line items

Columns are period end dates

Stockrow Weekly